FDA Approves Drug for Chronic Drooling in Children
The U.S. Food and Drug Administration today approved Cuvposa (glycopyrrolate) Oral Solution to treat chronic severe drooling caused by neurologic disorders in children ages 3 years to 16 years.
- FTC Issues Annual Financial Acts Enforcement Report to Federal Reserve
- Justice Department Requires Mill Divestitures in International Paper’s Acquisition of Temple-Inland
- Summit Import Corporation Issues Allergy Alert on Undeclared Eggs in Bin Bin Snow Rice Cracker 5.3oz Pack and Bin Bin Rice Cracker 15.8oz Bulk Pack
- FDA investigating illegal online sale of handheld dental X-ray units
- U.S. International Trade in Goods and Services, December 2011
Comments
Feel free to leave a comment...
and oh, if you want a pic to show with your comment, go get a gravatar!
You must be logged in to post a comment.